Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2020/10/028348
CTRI/2020/10/028348Completed未知

Evaluation of test-retest variability in perimetry using novel stimulus and algorithm among persons with glaucoma

MAHE0 sites230 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
230
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •Glaucoma participants: Early to advance glaucoma (Optic nerve damage, SAP reports indicating VF
  • •Normal participants: Diagnosed healthy eyes
  • •Best Corrected Visual Acuity (BCVA) of 0.1 logMAR or better
  • •Refractive error between ± 6.00 DS equivalent and cylindrical correction within ± 3.00 DC

Exclusion Criteria

  • •Glaucoma participants: Systemic diseases known to affect retina. Retinal pathology other than glaucoma. High progression of visual field damage.
  • •Normal participants: Any ocular pathology other than cataract. Systemic diseases affecting visual function or retina. Under any medication that affects vision.

Investigators

Sponsor
MAHE

Similar Trials

Not yet recruiting
Not Applicable
Comparing test-retest variability of Compass perimetry with the Humphrey Field Analyzer at the edges of glaucomatous scotomasglaucoma10018307
NL-OMON48106Oogziekenhuis Rotterdam30
Completed
Not Applicable
An Investigation of the Test-Retest Variability of Measures of the Fractional Enrichment of Glutamate/Glutamine in Healthy Adults Measured Using Selective Proton Observed, Carbon Edited (selPOCE) MRSDepressed mood disorders and disturbances, Schizophrenia and other psychotic disordersAlzheimers disease10012272schizophrenia
NL-OMON51033Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.28
Completed
Not Applicable
Assessment of Measurement Variability Across Automated Biometry DevicesMyopia
NCT06045325Berkeley Eye Center204
Completed
Not Applicable
A Study to evaluate the variability in delineation of the target volumes in Lung Cancer by comparing two techniques using Four- dimensional computed tomography.
CTRI/2016/09/007233TATA MEMORIAL HOSPITA30
Recruiting
Not Applicable
To observe for plethysmographic variability index as measurement of fluid requirement in patients getting operated under general anaesthesia
CTRI/2021/08/035964Tata Memorial Hospital